Get our free book (in Spanish or English) on rainwater now - To Catch the Rain.
Therapeutic Foam Technology
|Health Topic||Maternal mortality|
|Location||Africa, Asia, South America|
Problem being addressed
Post-partum hemorrhage is one of the leading causes of maternal mortality world-wide and it is difficult to control. Current popular methods of treatment involve drug injection and uterine massage, which are invasive and require skill and training.
Detailed description of the solution
Arsenal Medical is currently developing a foam material and foam delivery device that expands to the anatomical shape of any uterus while still maintaining its structure. It allows for minimally-invasive drug-delivery and effective control of hemorrhage.
Describe its relevance for resource-constrained settings
This device addresses maternal mortality in developing countries. It is especially well-suited for these regions because it is inexpensive and minimally invasive.
- Designed by: Arsenal Medical
- Address: 480 Arsenal Street, Watertown, MA 02472
- Website available here.
Arsenal Medical receives funding and grants from a variety of parties including venture capitalists, the Department of Defense, and the National Institute of Standards and Technology’s Technology Innovation Program (NIST-TIP). The company also received a $100,000 grant from the global health competition organized by the Bill and Melinda Gates Foundation in April 2011.
IP and copyright
Patent Name: Systems and Methods Relating to Polymer Foams Patent Number: 20110202016 Axiocore Trade Mark Serial Number: 77828046